FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1741-1751 October 21, 2004 Number 17 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Donald, P. R. Editorial by Quagliarello, V. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Tuberculous meningitis kills or disables more than half of those affected with the disease. Previous studies have been too small to determine whether adjunctive treatment with corticosteroids can reduce the risk of disability or death among adults with tuberculous meningitis, and the effect of coinfection with the human immunodeficiency virus (HIV) is unclear.

Methods We performed a randomized, double-blind, placebo-controlled trial in Vietnam in patients over 14 years of age who had tuberculous meningitis, with or without HIV infection, to determine whether adjunctive treatment with dexamethasone reduced the risk of death or severe disability after nine months of follow-up. We conducted prespecified subgroup analyses and intention-to-treat analyses.

Results A total of 545 patients were randomly assigned to groups that received either dexamethasone (274 patients) or placebo (271 patients). Only 10 patients (1.8 percent) had been lost to follow-up at nine months of treatment. Treatment with dexamethasone was associated with a reduced risk of death (relative risk, 0.69; 95 percent confidence interval, 0.52 to 0.92; P=0.01). It was not associated with a significant reduction in the proportion of severely disabled patients (34 of 187 patients [18.2 percent] among survivors in the dexamethasone group vs. 22 of 159 patients [13.8 percent] in the placebo group, P=0.27) or in the proportion of patients who had either died or were severely disabled after nine months (odds ratio, 0.81; 95 percent confidence interval, 0.58 to 1.13; P=0.22). The treatment effect was consistent across subgroups that were defined by disease-severity grade (stratified relative risk of death, 0.68; 95 percent confidence interval, 0.52 to 0.91; P=0.007) and by HIV status (stratified relative risk of death, 0.78; 95 percent confidence interval, 0.59 to 1.04; P=0.08). Significantly fewer serious adverse events occurred in the dexamethasone group than in the placebo group (26 of 274 patients vs. 45 of 271 patients, P=0.02).

Conclusions Adjunctive treatment with dexamethasone improves survival in patients over 14 years of age with tuberculous meningitis but probably does not prevent severe disability.

Source Information

From the Oxford University Clinical Research Unit at the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, and the Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom (G.E.T., K.S., N.J.W., J.J.F.); Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam (N.D.B., Nguyen H. Dung, H.T.Q., D.T.T.O., N.T.C.T., N.Q.H., N.T.T., N.N.H., N.T.N.L., N.N.L., Nguyen H. Duc, V.N.T., C.H.H.); and Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam (T.T.H.C., P.P.M., N.T.D., T.T.H.).

Address reprint requests to Dr. Thwaites at the Oxford University Clinical Research Unit, the Hospital for Tropical Diseases, 190 Ben Ham Tu, Quan 5, Ho Chi Minh City, Vietnam, or at guy.thwaites{at}btinternet.com.

Full Text of this Article

Related Letters:

Dexamethasone for Tuberculous Meningitis
Seligman S. J., Vagenakis A. G., Kyriazopoulou V., Marras T. K., Thwaites G. E., Quy H. T., Farrar J. J., Quagliarello V.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:628-630, Feb 10, 2005. Correspondence

This article has been cited by other articles:

• Lee, S. I., Park, J. H., Kim, J. H. (2008). Paradoxical progression of intracranial tuberculomas and anterior cerebral artery infarction. Neurology 71: 68-68 [Full Text]  
• McGee, S., Hirschmann, J. (2008). Use of Corticosteroids in Treating Infectious Diseases. Arch Intern Med 168: 1034-1046 [Abstract] [Full Text]  
• Takahashi, T., Tamura, M., Asami, Y., Kitamura, E., Saito, K., Suzuki, T., Takahashi, S. N., Matsumoto, K., Sawada, S., Yokoyama, E., Takasu, T. (2008). Novel Wide-Range Quantitative Nested Real-Time PCR Assay for Mycobacterium tuberculosis DNA: Development and Methodology. J. Clin. Microbiol. 46: 1708-1715 [Abstract] [Full Text]  
• Takahashi, T., Tamura, M., Asami, Y., Kitamura, E., Saito, K., Suzuki, T., Takahashi, S. N., Matsumoto, K., Sawada, S., Yokoyama, E., Takasu, T. (2008). Novel Wide-Range Quantitative Nested Real-Time PCR Assay for Mycobacterium tuberculosis DNA: Clinical Application for Diagnosis of Tuberculous Meningitis. J. Clin. Microbiol. 46: 1698-1707 [Abstract] [Full Text]  
• Murakami, S., Takeno, M., Oka, H., Ueda, A., Kurokawa, T., Kuroiwa, Y., Ishigatsubo, Y. (2008). Diagnosis of Tuberculous Meningitis Due to Detection of ESAT-6-Specific Gamma Interferon Production in Cerebrospinal Fluid Enzyme-Linked Immunospot Assay. CVI 15: 897-899 [Abstract] [Full Text]  
• Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W., Peterson, P. K. (2008). Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects. Clin. Microbiol. Rev. 21: 243-261 [Abstract] [Full Text]  
• Thwaites, G., Caws, M., Chau, T. T. H., D'Sa, A., Lan, N. T. N., Huyen, M. N. T., Gagneux, S., Anh, P. T. H., Tho, D. Q., Torok, E., Nhu, N. T. Q., Duyen, N. T. H., Duy, P. M., Richenberg, J., Simmons, C., Hien, T. T., Farrar, J. (2008). Relationship between Mycobacterium tuberculosis Genotype and the Clinical Phenotype of Pulmonary and Meningeal Tuberculosis. J. Clin. Microbiol. 46: 1363-1368 [Abstract] [Full Text]  
• Chan, E. D., Ong, C. W., Hsu, L. Y., Tambyah, P. A., Taha, M.-K., Alonso, J.-M., Siberry, G. K., McMillan, J. A., Mai, N. T. H., Thwaites, G., Farrar, J. J., Scarborough, M., Gordon, S., Peto, T. (2008). Corticosteroids for bacterial meningitis.. NEJM 358: 1399-1400 [Full Text]  
• Mai, N. T. H., Chau, T. T. H., Thwaites, G., Chuong, L. V., Sinh, D. X., Nghia, H. D. T., Tuan, P. Q., Phong, N. D., Phu, N. H., Diep, T. S., Chau, N. v. V., Duong, N. M., Campbell, J., Schultsz, C., Parry, C., Torok, M. E., White, N., Chinh, N. T., Hien, T. T., Stepniewska, K., Farrar, J. J. (2007). Dexamethasone in Vietnamese Adolescents and Adults with Bacterial Meningitis. NEJM 357: 2431-2440 [Abstract] [Full Text]  
• Bawa, S., McNally, J. (2007). A pain in the foot and a serious complication. JRSM 100: 284-285 [Full Text]  
• Harris, J. E., Green, J. A., Elkington, P. T., Friedland, J. S. (2007). Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion. J. Leukoc. Biol. 81: 548-556 [Abstract] [Full Text]  
• Harris, J. E., Fernandez-Vilaseca, M., Elkington, P. T. G., Horncastle, D. E., Graeber, M. B., Friedland, J. S. (2007). IFN{gamma} synergizes with IL-1{beta} to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis. FASEB J. 21: 356-365 [Abstract] [Full Text]  
• Harris, J. E., Nuttall, R. K., Elkington, P. T., Green, J. A., Horncastle, D. E., Graeber, M. B., Edwards, D. R., Friedland, J. S. (2007). Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo. J. Immunol. 178: 1199-1207 [Abstract] [Full Text]  
• Caws, M., Thwaites, G., Stepniewska, K., Lan, N. T. N., Duyen, N. T. H., Phuong, N. T., Huyen, M. N. T., Duy, P. M., Loc, T. H., Chau, T. T. H., van Soolingen, D., Kremer, K., Chau, N. V. V., Chinh, N. T., Farrar, J. (2006). Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous Meningitis. J. Clin. Microbiol. 44: 3934-3939 [Abstract] [Full Text]  
• Venkataramana, A., Pardo, C. A., McArthur, J. C., Kerr, D. A., Irani, D. N., Griffin, J. W., Burger, P., Reich, D. S., Calabresi, P. A., Nath, A. (2006). Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67: 383-388 [Abstract] [Full Text]  
• Simmons, C. P., Thwaites, G. E., Quyen, N. T. H., Torok, E., Hoang, D. M., Chau, T. T. H., Mai, P. P., Lan, N. T. N., Dung, N. H., Quy, H. T., Bang, N. D., Hien, T. T., Farrar, J. (2006). Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome. J. Immunol. 176: 2007-2014 [Abstract] [Full Text]  
• Elkington, P. T. G., Nuttall, R. K., Boyle, J. J., O'Kane, C. M., Horncastle, D. E., Edwards, D. R., Friedland, J. S. (2005). Mycobacterium tuberculosis, but Not Vaccine BCG, Specifically Upregulates Matrix Metalloproteinase-1. Am. J. Respir. Crit. Care Med. 172: 1596-1604 [Abstract] [Full Text]  
• Simmons, C. P., Thwaites, G. E., Quyen, N. T. H., Chau, T. T. H., Mai, P. P., Dung, N. T., Stepniewska, K., White, N. J., Hien, T. T., Farrar, J. (2005). The Clinical Benefit of Adjunctive Dexamethasone in Tuberculous Meningitis Is Not Associated with Measurable Attenuation of Peripheral or Local Immune Responses. J. Immunol. 175: 579-590 [Abstract] [Full Text]  
• Blumberg, H. M., Leonard, M. K. Jr, Jasmer, R. M. (2005). Update on the Treatment of Tuberculosis and Latent Tuberculosis Infection. JAMA 293: 2776-2784 [Abstract] [Full Text]  
• Seligman, S. J., Vagenakis, A. G., Kyriazopoulou, V., Marras, T. K., Thwaites, G. E., Quy, H. T., Farrar, J. J., Quagliarello, V. (2005). Dexamethasone for Tuberculous Meningitis. NEJM 352: 628-630 [Full Text]  
• Lewin, J. J. III, Lapointe, M., Ziai, W. C. (2005). Central Nervous System Infections in the Critically Ill. Journal of Pharmacy Practice 18: 25-41 [Abstract]  
• (2005). Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults. JWatch Neurology 2005: 5-5 [Full Text]  
• (2004). New Data on Steroids in Tuberculous Meningitis. JWatch General 2004: 3-3 [Full Text]  
• (2004). Are Steroids Beneficial in the Treatment of Tuberculous Meningitis?. JWatch Infect. Diseases 2004: 7-7 [Full Text]  
• Quagliarello, V. (2004). Adjunctive Steroids for Tuberculous Meningitis -- More Evidence, More Questions. NEJM 351: 1792-1794 [Full Text]